Block, Blood, or Both? Outcomes, Opportunities, and Barriers in Colorectal Cancer Universal Testing
- PMID: 34089853
- PMCID: PMC9109597
- DOI: 10.1016/j.cgh.2021.05.058
Block, Blood, or Both? Outcomes, Opportunities, and Barriers in Colorectal Cancer Universal Testing
Conflict of interest statement
Conflicts of interest
The author discloses no conflicts.
Comment on
-
Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study.Clin Gastroenterol Hepatol. 2022 Mar;20(3):e508-e528. doi: 10.1016/j.cgh.2021.04.013. Epub 2021 Apr 20. Clin Gastroenterol Hepatol. 2022. PMID: 33857637
-
Universal Immunohistochemistry for Lynch Syndrome: A Systematic Review and Meta-analysis of 58,580 Colorectal Carcinomas.Clin Gastroenterol Hepatol. 2022 Mar;20(3):e496-e507. doi: 10.1016/j.cgh.2021.04.021. Epub 2021 Apr 19. Clin Gastroenterol Hepatol. 2022. PMID: 33887476
References
-
- Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009;11:35–41. - PMC - PubMed
-
- Giardiello FM, Allen JI, Axilbund JE, et al. US Multi-Society Task Force on Colorectal Cancer. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology 2014;147:502–526. - PubMed
-
- National Comprehensive Cancer Network. Genetic/Familial High-Risk Assessment: Colorectal (Version 1.2021). Available at: https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf. Accessed May 22, 2021. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
